₨ 100,000
Herceptin (trastuzumab) is a cancer medication used to treat certain types of breast and stomach cancers. The medication is a monoclonal antibody that targets the HER2 protein, which is found in high quantities on some cancer cells (HER2-positive cancers). By binding to this protein, trastuzumab helps to stop the growth of these cancer cells and signals the body's immune system to destroy them.
Key Information
- Active Ingredient: The medication's active ingredient is trastuzumab.
- Dosage: The image shows a 440 mg vial of concentrated powder for solution for infusion.
- Uses: Herceptin is used for the treatment of HER2-positive early breast cancer, metastatic breast cancer, and metastatic gastric (stomach) or gastroesophageal junction cancer.
- Administration: The medication is administered as an intravenous infusion (a drip into a vein) or as an injection under the skin.
- Manufacturer: The product is manufactured by Roche.
Important Safety Information
- Herceptin can cause serious side effects, including heart problems, infusion reactions, and lung problems. Patients are typically monitored for heart function before and during treatment.
- The medication may cause harm to an unborn baby. Women of reproductive potential are advised to use effective contraception during treatment and for at least 7 months after the last dose.
- It is not recommended for use during pregnancy or while breastfeeding.
- Herceptin should not be self-administered and must be given by a trained doctor or healthcare professional.
- Common side effects may include fever, chills, fatigue, diarrhea, headache, nausea, and rash.
Disclaimer: This information is for general knowledge and is not a substitute for professional medical advice. Always consult with a qualified healthcare provider for any health concerns or before starting any new medication.
₨ 10,000
